ID

23568

Description

Quality Of Life While Receiving Faslodex; ODM derived from: https://clinicaltrials.gov/show/NCT00643513

Link

https://clinicaltrials.gov/show/NCT00643513

Keywords

  1. 7/9/17 7/9/17 -
Uploaded on

July 9, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00643513

Eligibility Breast Cancer NCT00643513

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologic and/or cytological proven breast cancer.
Description

Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0678222
patients with metastases of breast cancer ± postmenopausal primary tumor ≥12 months.
Description

Secondary malignant neoplasm of female breast | Postmenopausal state | Primary tumor Disease length

Data type

boolean

Alias
UMLS CUI [1]
C0346993
UMLS CUI [2]
C0232970
UMLS CUI [3,1]
C0677930
UMLS CUI [3,2]
C0872146
positive oestrogen receptors (er+), positive progesterone receptors (pgr+) or unknown hormonal receptors (if duration between surgery and metastasis occurring is not less 2 years) which are indirect confirmation of hormone sensitive tumor.
Description

Estrogen receptor positive | Progesterone receptor positive | Hormone Receptor Unknown | Operative Surgical Procedures | Neoplasm Metastasis | Hormone sensitive malignancy status

Data type

boolean

Alias
UMLS CUI [1]
C0279754
UMLS CUI [2]
C0279759
UMLS CUI [3,1]
C0019929
UMLS CUI [3,2]
C0439673
UMLS CUI [4]
C0543467
UMLS CUI [5]
C0027627
UMLS CUI [6]
C4270758
ecog performance status of ≤ 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
patient willingness to take part in the programm
Description

Study Subject Participation Status Willing

Data type

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0600109
life expectancy of more than 6 months.
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
patient ability to complete a questionnaire.
Description

Questionnaire Completion Ability

Data type

boolean

Alias
UMLS CUI [1,1]
C0034394
UMLS CUI [1,2]
C0205197
UMLS CUI [1,3]
C0085732
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications for faslodex therapy
Description

Medical contraindication Faslodex

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0701491
other anticancer therapy (chemotherapy, hormonal therapy with other drugs, radiotherapy), except for radiotherapy of sites which are not only measurable or evaluable manifestation of disease.
Description

Cancer treatment | Chemotherapy | Hormone Therapy | Investigational New Drugs | Therapeutic radiology procedure | Measurable Disease | Evaluable Disease

Data type

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C0392920
UMLS CUI [3]
C0279025
UMLS CUI [4]
C0013230
UMLS CUI [5]
C1522449
UMLS CUI [6]
C1513041
UMLS CUI [7]
C1516986

Similar models

Eligibility Breast Cancer NCT00643513

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma
Item
histologic and/or cytological proven breast cancer.
boolean
C0678222 (UMLS CUI [1])
Secondary malignant neoplasm of female breast | Postmenopausal state | Primary tumor Disease length
Item
patients with metastases of breast cancer ± postmenopausal primary tumor ≥12 months.
boolean
C0346993 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0677930 (UMLS CUI [3,1])
C0872146 (UMLS CUI [3,2])
Estrogen receptor positive | Progesterone receptor positive | Hormone Receptor Unknown | Operative Surgical Procedures | Neoplasm Metastasis | Hormone sensitive malignancy status
Item
positive oestrogen receptors (er+), positive progesterone receptors (pgr+) or unknown hormonal receptors (if duration between surgery and metastasis occurring is not less 2 years) which are indirect confirmation of hormone sensitive tumor.
boolean
C0279754 (UMLS CUI [1])
C0279759 (UMLS CUI [2])
C0019929 (UMLS CUI [3,1])
C0439673 (UMLS CUI [3,2])
C0543467 (UMLS CUI [4])
C0027627 (UMLS CUI [5])
C4270758 (UMLS CUI [6])
ECOG performance status
Item
ecog performance status of ≤ 2
boolean
C1520224 (UMLS CUI [1])
Study Subject Participation Status Willing
Item
patient willingness to take part in the programm
boolean
C2348568 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy of more than 6 months.
boolean
C0023671 (UMLS CUI [1])
Questionnaire Completion Ability
Item
patient ability to complete a questionnaire.
boolean
C0034394 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Faslodex
Item
contraindications for faslodex therapy
boolean
C1301624 (UMLS CUI [1,1])
C0701491 (UMLS CUI [1,2])
Cancer treatment | Chemotherapy | Hormone Therapy | Investigational New Drugs | Therapeutic radiology procedure | Measurable Disease | Evaluable Disease
Item
other anticancer therapy (chemotherapy, hormonal therapy with other drugs, radiotherapy), except for radiotherapy of sites which are not only measurable or evaluable manifestation of disease.
boolean
C0920425 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C0013230 (UMLS CUI [4])
C1522449 (UMLS CUI [5])
C1513041 (UMLS CUI [6])
C1516986 (UMLS CUI [7])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial